It seems like Calocurb is very well aware that people will not take it as recommended
Key results 20% reduction in major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) 3 19% reduction in all-cause mortality 3 Average weight loss of approximately 9.4% 3 For people already on statins who also have obesity, the SELECT data shows that adding Wegovy reduced their rate of heart attacks, strokes, and cardiovascular death by one-fifth, even though they were already receiving optimised statin therapy

Dietary and lifestyle modifications: Patients benefit from specific guidance regarding eating patterns and food choices: Smaller, more frequent meals Consuming 5-6 small meals rather than 3 large meals reduces gastric distension Slower eating pace Taking 20-30 minutes per meal and chewing thoroughly Avoiding high-fat foods Fatty meals delay gastric emptying further and may exacerbate symptoms Limiting very high-fiber foods During symptomatic periods, as these can worsen bloating Limiting carbonated beverages Reducing bloating and distension Adequate hydration Maintaining fluid intake between meals rather than with meals Remaining upright after eating Avoiding recumbent positions for 2-3 hours post-meal Symptomatic management: When lifestyle modifications prove insufficient, pharmacological interventions may provide relief
We do not accept insurance, FSA, HSA, Medicare, or Medicaid for compounded medications or weight loss services
Furthermore, the GLP-1/Amylin combos category is expanding more quickly due to continuing research, rising investment in novel medication development, and rising demand for treatments that are more effective than monotherapies